r e p o r t t o o u r c o m m u n i t i e s

Transcription

1 r e p o r t t o o u r c o m m u n i t i e s

2 w e a r e n y b c. As a Center of Excellence, our strength lies in collaboration with supporters like you to provide safe, reliable, cutting-edge blood products and services and fulfill a vital community need.

3 y o u a r e n y b c. At the core of our exceptional service is the dedication of employees, volunteers, donors, and community and corporate partners whose efforts provide the gift of life. For this, we thank you. c o n t e n t s 2 Quality, Service, Innovation, Leadership, Impact 4 From the President & Chairman 6 Medical Programs & Services 8 Operations & Manufacturing 10 Customer Service 12 Quality & Regulatory Affairs 14 National Cord Blood Program 16 Lindsley F. Kimball Research Institute 18 Corporate & Community Relations 20 NYBC Leadership 22 Blood Donation Centers

4 q u a l i t y + s e r v i c e + i n n o v a t i o n New York Blood Center is the single largest nonprofit, community-based blood collection and distribution organization in the United States. Since 1964, we have fulfilled a lifesaving mission to provide the highest quality blood and stem cell products, donor and patient medical services, and innovative research. Our vision is to develop people and partnerships and continue to be recognized as a comprehensive center of excellence worldwide. Front Cover: In June 2006, when she was only four years old, Simone Schultz was diagnosed with acute lymphocytic leukemia. She received red cell and platelet transfusions from seven anonymous donors at Maria Fareri Children s Hospital in Hudson Valley, New York. Each donor helped Simone win her fight against cancer. 2

5 + l e a d e r s h i p = i m p a c t Through the combined efforts of our geographic blood services operations, approximately 2,000 units of blood products are collected each day and distributed to more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, Connecticut, and Pennsylvania. Our impact is local, national, and global. We provide over 1 million blood products a year to meet the daily transfusion needs of cancer and surgery patients, accident and burn victims, newborns and mothers delivering babies, AIDS and sickle cell anemia patients, organ transplant recipients, and many others. We are also home to the National Cord Blood Program at the Howard P. Milstein National Cord Blood Center, the oldest, largest public cord blood bank in the world. 3

6 f r o m t h e p r e s i d e n t & c h a i r m a n New York Blood Center was honored with a 2009 Buildings magazine Projec t Innovations Award for operational excellence in buildings, receiving Grand Prize in the modernization categor y for the transformation of this 75,000 square foot warehouse into a state - of-the -ar t blood processing and research facility. 4

7 Christopher D. Hillyer, MD President & CEO Howard P. Milstein Chairman, Board of Trustees It starts with one person s selfless act of generosity. Communities are strengthened and lives are saved every day when blood donors give patients like Simone Schultz a chance to survive and thrive. At four years old, Simone was diagnosed with acute lymphocytic leukemia. She received red cell and platelet transfusions at Westchester Medical Center s Maria Fareri Children s Hospital in Hudson Valley, New York. New York Blood Center (NYBC) is honored to serve as a lifeline for Simone and other patients who bravely face devastating illness and accidents with courage and vigor. We are resolute in our commitment to the health and vitality of those whose lives depend on us. From transplants to heart surgeries, today s advanced medical care relies on blood transfusions. NYBC has a longstanding tradition of providing blood products and services to the 20 million residents living in the greater metropolitan area. Thousands of men, women, and children need donated blood products each day, and this need could not be met without the dedication of volunteers, blood donors, contributors, and community and corporate partners. We continue to build on a lifesaving legacy of quality, service, innovation, and leadership. Strong, effective leadership coupled with the outstanding contributions and generosity of all those who make the work we do possible, means our organization is well positioned to remain a Center of Excellence in the communities we serve. This report reveals what makes NYBC a leading Center of Excellence in blood banking: the strength of our exemplary leadership team and staff and the power of our communities united in commitment, purpose, and action. Collaboration and partnerships build on our success to directly benefit countless patients. Corporate and community outreach initiatives like our Little Doctors Program and Student Scholarship Program educate young people and inspire them to a future in leadership, science, and public service. We reach medically underserved communities through our PreciseMatch blood type diversity programs as well as Project ACHIEVE, an initiative of NYBC s Laboratory of Infectious Disease Prevention, which conducts behavioral intervention trials and research studies as part of an international effort to discover a preventive HIV vaccine. Through research advancements, our impact is wide-ranging and far-reaching. The National Cord Blood Program at NYBC s Howard P. Milstein National Cord Blood Center is the single largest public cord blood bank in the world, and groundbreaking research at our Lindsley F. Kimball Research Institute continues to lead the way in blood disease prevention, treatments, cures, and therapies. We are NYBC. You are NYBC. Together, we will carry on the tradition of excellence in all that we do. We value the confidence and trust you place in us and will do our best to continue to earn that trust now and in the future. Sincerely, Howard P. Milstein Chairman, Board of Trustees Christopher D. Hillyer, MD President & CEO 5

8 m e d i c a l p r o g r a m s & s e r v i c e s Radhika Sawh receives regular blood transfusions at Winthrop Hospital Cancer Center for Kids in Mineola, New York. 6

9 w h a t w e d o Delivering the highest quality blood products and services to meet the critical needs of patients like Radhika is our number one priority. Beth Shaz, MD Vice President & Chief Medical Officer Radhika Sawh requires red cell blood transfusions to treat Thalassemia, a genetic disorder that occurs when red blood cells cannot make sufficient amounts of the major components of the hemoglobin protein which carries oxygen throughout the body. With a rapidly changing healthcare environment, shifts in demand, and greater competition, ensuring a sufficient blood supply to meet the daily needs of patients like Radhika can be challenging. NYBC aims to meet these challenges every day through our innovative medical programs and services. With a well-established, growing medical agenda, we provide education to patients, physicians, and researchers and manage transfusion services for hospital partners. Our Clinical Services Program provides more than 8,500 highly specialized patient care procedures each year, and our Hemophilia Services Program ensures over 500 local patients with hemophilia and other blood clotting disorders have access to the clotting factors they need to survive 24 hours a day, seven days a week. NYBC s Special Donor and Community Health Services health outreach initiatives include a Cardiovascular Disease Risk Screening project and Hereditary Hemochromatosis Phlebotomy Program. Our experienced clinicians notify and counsel donors of any result that will defer them from donating blood temporarily or permanently; provide counseling and information about follow-up care and available resources; and explore treatment options and support services available to donors and their families. Our Bone Marrow Registry Program works in conjunction with the Be The Match Registry, operated by the National Marrow Donor Program, to provide bone marrow grafts for transplantation to patients suffering from leukemia and other lifethreatening diseases. We recruit potential unrelated, volunteer bone marrow and peripheral blood stem cell donors to join the national registry and guide them through the process of further testing and donation, should they be called as a match for a patient. In 2010, we surpassed 1,000 donations coordinated through the program which continues to support the needs of patients in our communities and worldwide. m i l e s t o n e s For over 30 years, the Professional Education Department has sponsored an Accreditation Council for Graduate Medical Education (ACGME) Transfusion Medicine Fellowship Program. Our Cellular Therapy Laboratory is a pioneer in personalized medicine. Bone marrow transplantation can cure blood malignancies like leukemia and genetic disorders such as sickle cell disease. Successful transplantation depends on availability of quality hematopoietic stem cell (blood forming) products. Each year, the laboratory processes, cryopreserves, stores, and releases for transplantation more than 600 unique products for individual patients. Since 2005, NYBC s PreciseMatch Program has accurately matched donated blood with patients in need, going beyond typical A, B, and O blood typing to ensure our multicultural patient population has access to a more diverse supply of blood products. 7

10 o p e r a t i o n s & m a n u f a c t u r i n g NYBC component laboratory where blood is separated into red cells, platelets, and plasma to benefit several patients. 8

11 w h a t w e d o We constantly seek to implement processes and procedures that help us achieve optimal operational efficiency. Elizabeth J. McQuail Senior Vice President Operations & Manufacturing NYBC continues to build on our commitment to cost efficiency and customer service through the creation of a new organizational structure. We have merged our former Core Operations and Blood Services divisions to align ourselves along functional lines and take advantage of the expertise that exists within our leadership. The new entity, Operations and Manufacturing, now encompasses donor marketing and recruitment, collections and core operations, operations support, logistics, and shared services. Operations and Manufacturing is an essential, central function of NYBC, implementing best practices in blood collection, manufacturing, and distribution. We turn donations into blood products through our two component processing laboratories in Westbury and Long Island City, New York. Operations and Manufacturing includes all blood testing laboratories such as the Laboratory of Immunohematology and Genomics which identifies blood group antigens and antibodies; provides antigen-negative red cells; educates NYBC fellows, visiting physicians, and other visitors; and serves hospitals in our regions as well as national and international laboratories. The Frozen Blood Laboratory is an integral part of NYBC, providing rare products to patients in need of highly categorized antigennegative blood. The laboratories maintained within Operations and Manufacturing perform quality control on our blood products to ensure their safety, quality, integrity, purity, and potency, working directly with our hospital customers and Client Services Department which plays a critical role as a single point of access for our hospital customers to order specialty products such as HLAmatched platelets and life-saving granulocyte products. Another primary focus of Operations and Manufacturing is investing in new systems that better support our operations, planning, and decision-making. Process improvement is ongoing as we identify, analyze, and improve existing organizational processes to benefit patients on a local, national, and global scale. m i l e s t o n e s The Laboratory of Immunohematology and Genomics, one of the world s leading reference laboratories, together with the Laboratory of Immunochemistry, pioneered the use of DNA analysis as an adjunct to serological testing. Under the leadership of Director Connie Westhoff, SBB, PhD, the lab continues to identify new blood group antigens and support patient needs. Blood banking industry leaders from Brazil and China visited our state-of-the-art Long Island City facility in International visitors learn more about how NYBC lab operations can help improve blood manufacturing around the globe. For hospital blood banks, summer months are usually a time of increased demand and decreased supply, but 2009 marked the first year NYBC did not issue a summer emergency appeal for donors and maintained an adequate supply of blood products to meet patient needs. The hard work and dedication of our employees helped us achieve this milestone, and we salute them. 9

12 c u s t o m e r s e r v i c e Blood recipient Heather McNamara attends a blood drive in her honor which yielded 116 units of blood and red cells. 10

13 w h a t w e d o Cultivating and investing in our customer relationships is paramount to NYBC s life-saving mission. Robert Purvis Vice President Customer Service In 2005, Heather McNamara was diagnosed with an abnormal inflammatory myofibroblastic tumor that cut off circulation to her major organs. Prior to surgery, Heather received oral and intravenous chemotherapy, and blood transfusions were required to maintain her blood and platelet count. She needed an additional eight pints of blood during her 23-hour operation. Heather, and patients like her, is what drives our commitment to exemplary customer service. It is NYBC s top priority to continuously improve and enhance the service and support we provide while maintaining the highest degree of care and professionalism. We proactively seek to build lasting relationships with our donors and volunteers as well as hospitals and other organizations we partner with to ensure the continued success of our customer relationships. An organization s most important asset is its customers. Without them, we could not provide the essential services our communities have come to expect from NYBC. As a Center of Excellence, we aim to anticipate, meet, and exceed community needs and deliver quality blood products and services that save lives. Customer service leadership is key to further developing and improving NYBC s internal and external communication efforts in alignment with our strategic goals and objectives. We focus on these elements because we understand how critical they are to our success and the health of the communities we serve. In all ways, we pursue true service excellence to touch the lives of individuals who rely on the generosity of the 2,000 volunteer donors needed each day to give the gift of life through blood donation. NYBC is proud to serve as a strong patient advocate and trusted community partner today to ensure a healthier tomorrow. m i l e s t o n e s Each year, the Association of Donor Recruitment Professionals (ADRP), an international organization dedicated to providing education, development, and resources for blood donor recruitment professionals, recognizes the innovation of organizations dedicated to advancing its mission. Our 2009 media campaign The Firefighter and the Doctor-Why Blood Donation Matters, produced by NYBC s Corporate Communications Department, was honored with a 2010 ADRP Television Public Service Announcement of the Year Award. The campaign featured NYBC President and CEO Christopher D. Hillyer, MD, along with Matt Long, New York City firefighter, blood recipient, and donor (pictured below). NYBC will launch a new Customer Service Call Center designed to provide customers with a central point of contact and meet the need for reliable, dependable, and consistent customer service and support. The NYBC Customer Service Team has been established to further build and strengthen customer relationships, educate customers about NYBC products and services, and broaden face-to-face communication with all levels of our growing customer base. 11

14 q u a l i t y & r e g u l a t o r y a f f a i r s Laboratory technicians process blood components at NYBC s state-of-the-art facility in Long Island City, New York. 12

15 w h a t w e d o We are dedicated to managing quality efficiently, systematically, and proactively in the daily operations of New York Blood Center. Eva Quinley, MS, MT(ASCP)SBB Senior Vice President Quality & Regulatory Affairs NYBC s strong commitment to quality is reflected in our mission and vision, and our operations and medical senior management teams are actively engaged with Quality and Regulatory Affairs (QRA) in all matters pertaining to quality. Blood banking is perhaps one of the most regulated industries in the United States. QRA provides oversight, guidance, and support to all other operations at NYBC, ensuring the products and services we produce are of the highest possible quality. QRA staff maintain a cooperative relationship and regular communication with all inspectional agencies. As a licensed blood center, NYBC must comply with federal and state regulations and is inspected frequently by the Food and Drug Administration (FDA) and both the New York and New Jersey Departments of Health. NYBC is accredited by American Association of Blood Banks (AABB), the professional organization for transfusion medicine and related cellular therapies, as well as by FACT, the Foundation for the Accreditation of Cellular Therapies. Compliance with the regulations and standards of these organizations is a major QRA priority. We have a thorough internal audit program where both routine and special focused audits are used to proactively improve the quality of our processes and services. Training and development of staff is critical to NYBC s success. A part of QRA, the Training and Development Department works with management to ensure robust training programs are in place and all staff are well trained for the tasks they perform. There are continuing education opportunities and annual training updates in critical areas such as safety, compliance, and ethics. The safety of our staff, donors, and visitors is of primary importance. The Environmental Health and Safety Department of QRA ensures NYBC is compliant with all applicable regulations and standards, and through localized Safety Committees, we conduct routine safety inspections of all our facilities. We also maintain an Emergency Preparedness Plan, and staff are trained in how to respond promptly and effectively to a wide variety of emergencies. m i l e s t o n e s QRA will develop and implement an online learning management system to track training for NYBC staff as well as serve as a vehicle for the dissemination of online training. The QRA team will create a more robust internal audit group with independent auditors to improve NYBC operations by evaluating and assessing significant new or changing services, processes, operations, and controls concurrent with their development and implementation. Both NYBC s Emergency Preparedness Plan and Quality Manual have undergone extensive evaluation, revisions, and updates. The Quality Manual provides a description of NYBC operations from a quality standpoint, and as an adjunct to the manual, a Quality Plan has been developed to outline a timeline for closing any gaps in quality. 13

16 l i n d s l e y f. k i m b a l l r e s e a r c h i n s t i t u t e With so many health conditions closely tied to blood, LFKRI is at the forefront of some of the world s most vital research. 14

17 w h a t w e d o Our research efforts propel blood and bloodrelated disease knowledge and discoveries to new heights. Mohandas Narla, DSc Vice President Director, Lindsley F. Kimball Research Institute Lindsley F. Kimball Research Institute s (LFKRI) world-renowned scientists lead some of the most innovative hematology and transfusion medicine research in the world. Our research has paved the way for new blood-related products, techniques, and therapies as well as numerous landmark patents. LFKRI is home to nearly 100 scientists and staff in more than a dozen laboratories working to discover life-saving solutions that result in improved patient outcomes, breakthrough cures, and advanced treatment for an array of blood-related diseases. Our laboratories develop novel approaches to treating infectious and blood-borne illnesses, immune system disorders, and red cell and platelet diseases. Researchers work in a range of areas, including biochemistry, molecular and cell biology, genetics, gene therapy, virology, and immunology. This crucial research impacts all areas of science, blood-related conditions, and transfusion medicine. We continue to research global health threats and work toward developing treatments for malaria, sickle cell disease, and severe acute respiratory syndrome (SARS). From the discovery of the first HIV-fusion inhibitor to treat AIDS to the development of a solvent detergent which inactivates viruses in blood plasma, LFKRI has made an indelible mark on transfusion medicine. m i l e s t o n e s LFKRI is a leader in AIDS research, conducting clinical trials of candidate HIV vaccines and developing strategies for changing the behavior of at-risk populations. Established in 1993 as part of LFKRI s Laboratory of Infectious Disease Prevention and under the leadership of Beryl Koblin, PhD, Project ACHIEVE advances awareness of HIV prevention, developing detailed epidemiological studies on the prevalence of HIV infection in New York City. LFKRI scientists have molecularly characterized a number of clinically relevant red cell blood group antigens which could potentially lead to the development of DNA-based typing of blood and improved transfusion practices. NYBC s Office of Patents and Licensing manages more than 200 patents and patent applications derived from research conducted at LFKRI, leading to new products and processes that significantly improve patient care. LFKRI is a part of the Myeloproliferative Disorders Research Consortium, an international group of researchers working to better understand the causes of myeloproliferative disorders (MPD) and develop improved methods of diagnosis and treatment. MPD s are conditions that cause blood cells (platelets and white and red blood cells) to grow abnormally in the bone marrow. Further knowledge about these cancer cells and the effects of treatment may lead to improvements in current therapies and the development of entirely new treatments. 15

18 n a t i o n a l c o r d b l o o d p r o g r a m Cord blood units are processed for transplantation and research at NYBC s National Cord Blood Program laboratories. 16

19 w h a t w e d o We are heartened that more than 55,000 mothers have entrusted us with their precious gifts of life. Pablo Rubinstein, MD Vice President Director, National Cord Blood Program It was more than 17 years ago when the National Cord Blood Program (NCBP) at NYBC s Howard P. Milstein National Cord Blood Center opened its doors to serve the global community as the first public cord blood bank in the world. With over 55,000 donations and more than 4,100 patients transplanted at 220-plus transplant centers worldwide, we continue to advance the use of umbilical cord blood as a potential treatment for many diseases. Umbilical cord blood units are now used as a possible treatment for over 65 conditions, including acute leukemia, lymphoma, sickle cell anemia, and other lethal diseases of the blood or immune system. Our work helps patients whose only chance of survival is a transplant that replaces the diseased cells in their bone marrow with healthy cells. NYBC pioneered the use of umbilical cord blood as a source of hematopoietic (bloodforming) stem cells for bone marrow restoration. After a baby is born and the umbilical cord is cut, blood the baby no longer needs remains in the placenta and umbilical cord. This cord blood can be collected after the placenta is delivered without risk to the mother or baby. Studies indicate that cord blood transplants may work well even when not perfectly matched to patients, which would be a special benefit for those with rare tissue types, including patients from ethnically diverse populations. m i l e s t o n e s Cord blood is currently considered an experimental source of hematopoietic stem cells. However, The New England Journal of Medicine featured NCBP s study of results from its first 562 transplant recipients, showing cord blood transplants may be useful for patients with certain disease states. A groundbreaking NCBP study led by Andromachi Scaradavou, MD, and colleagues from NYBC and Leiden University in the Netherlands, showed how matching non-inherited maternal antigens (NIMA) with mismatched donor leukocyte antigens may improve the outcome of cord blood transplants. Thus, NIMA may augment the number of matches for patients. The study was published by the Proceedings of the National Academy of Sciences (November 9, 2009); featured in the December 1, 2009 edition of the American Society for Blood and Marrow Transplantation s ASBMT enews; and in the December 7, 2009 Time magazine article The Year in Health From A to Z. In addition to clinical therapies, NCBP makes cord blood units (CBUs) available for stem cell research. Research-use CBUs are donated by the mother after being notified that the unit does not meet criteria for transplantation. Between 2008 and 2009, NYBC provided nearly 4,000 research-use CBUs to 14 investigators at nine institutions, including: Memorial Sloan-Kettering Cancer Center, New York University, University of Illinois, Mount Sinai School of Medicine, University of Minnesota, Rockefeller University, and University of Miami. 17

20 c o r p o r a t e & c o m m u n i t y r e l a t i o n s William J. Mullaney, President of U.S. Business for MetLife, cuts the ribbon at NYBC s donor coach launch event. 18

21 Our community and corporate partners provide the support and leadership essential to both our institution and our vital mission. w h a t w e d o Our success as a Center of Excellence is only possible through the strength of our partnerships. NYBC continues to build on a legacy of strong collaboration with a wide range of corporate and community organizations. We are privileged to partner with many individuals and organizations that are fundamental in helping us better serve our communities. Led by William J. Mullaney, President of U.S. Business for MetLife, our Volunteer Leadership Campaign engages scores of outstanding leaders from organizations committed to NYBC. Since 1980, this program has been a critical source of influential and dedicated volunteers who reach out to others in a concerted effort to further our life-saving mission. From executives at global corporations to baseball team owners, public officials, high-ranking military officers, and leaders from educational and faithbased organizations, we rely on the work of this diverse cadre of volunteers. In addition to the volunteer campaign, our Blood Services Community Relations Advisory Council provides input and counsel across a wide array of activities, including blood donor recognition, general management assistance, customer service, and donor marketing. Fundraising is also a feature of the work of our Corporate and Community Relations Department. Financial contributions help fund research at NYBC s Lindsley F. Kimball Research Institute and National Cord Blood Program and further our work in blood, educational, and medical services. m i l e s t o n e s The 2009 Biennial Chairman s Dinner raised a record $1.4 million and saluted BNY Mellon and the New York Yankees as Champions of Life for their leadership and service to our organization. Employees of New York City, led by Mayor Michael Bloomberg and Commissioner Martha K. Hirst, continued to be NYBC s largest source of blood donations, giving more than 35,000 gifts of life. The New York Yankees High School Blood Donor Championships 13th Annual Game Night celebrated a record 62,000 annual donations made from New York and New Jersey high schools and 500,000 donations made since the program s inception in Despite a challenging economic climate, volunteer leadership maintained or grew support in key business sectors. From law firms to the real estate sector, and from financial services to nonprofit organizations, involvement of leadership made a positive impact and contribution to our mission. 19

22 n y b c l e a d e r s h i p Chris Herder Photography Seated from left to right: David Tendler, Owen Garrick, MD, Harriet Edelman, Nicholas Scoppetta, Aaron R. Marcu Standing from left to right: William W. Crouse, Howard P. Milstein, Christopher D. Hillyer, John R. Mullen, Morton Spivack, Marc Kramer b o a r d o f t r u s t e e s William W. Crouse Harriet Edelman Owen Garrick, MD Christopher D. Hillyer, MD Michael W. Hodin, PhD (not pictured) Marc Kramer Aaron R. Marcu Howard P. Milstein John R. Mullen Robert A. Schwartz (not pictured) Nicholas Scoppetta Howard Sloan (not pictured) Morton Spivack, MD (retired, October 2010) David Tendler John Zuccotti (not pictured) 20

23 e x e c u t i v e s t a f f Christopher D. Hillyer, MD President & Chief Executive Officer Ollie Cheatham Acting Senior Vice President Human Resources Lawrence Hannigan Vice President & Chief Financial Officer Elizabeth J. McQuail Senior Vice President Operations & Manufacturing Mohandas Narla, DSc Vice President Director, Lindsley F. Kimball Research Institute Robert Purvis Vice President Customer Service Eva Quinley, MS, MT(ASCP)SBB Senior Vice President Quality & Regulatory Affairs Pablo Rubinstein, MD Vice President Director, National Cord Blood Program Jordana G. Schwartz Acting General Counsel Beth Shaz, MD Vice President & Chief Medical Officer Jay Valinsky, PhD Vice President Information & Technology 21

24 b l o o d d o n a t i o n c e n t e r s h u d s o n v a l l e y Carmel Fire Department 94 Gleneida Avenue Carmel, NY Cronomer Valley Fire Department North Plank Road Newburgh, NY Dan Leghorn Engine Company 426 South Plank Road Newburgh, NY Elmsford Donor Center 525 Executive Boulevard Elmsford, NY Hudson Valley Blood Services Donor Center 51 Albany Avenue Kingston, NY IBM 416 Building, Main Complex Route 9 Poughkeepsie (Enter at 415 Lobby) Poughkeepsie, NY IBM East Fishkill Donor Center Route 52, Building 320 Hopewell Junction, NY Lawrence Hospital 55 Palmer Avenue Bronxville, NY Middletown Community Donor Center Howard Johnson s 551 Route 211 East Middletown, NY Northern Westchester Hospital Donor Center 400 East Main Street (North Building, 1st Floor) Mt. Kisco, NY Rockland Blood Center 25 Smith Street Nanuet, NY Vassar Hospital Donor Center 45 Reade Place Poughkeepsie, NY l o n g i s l a n d Bohemia Donor Center 3125 Veterans Highway Bohemia, NY Lake Success Donor Center 2500 Marcus Avenue (¼ mile east of Lakeville Road) Lake Success, NY Melville Donor Center 905 Walt Whitman Road (Route 110, north of Northern State Parkway) Melville, NY

25 b l o o d Port Jefferson Station Donor Center 1010 Route 112 (100 yards south of Route 347) Port Jefferson Station, NY Riverhead Donor Center 1149 Old Country Road (Across from Target) Riverhead, NY Rockville Centre Donor Center 290 Sunrise Highway Rockville Centre, NY n e w j e r s e y Clark Volunteer Emergency Squad 875 Raritan Road Clark, NJ Flemington Elks Lodge Route 31 Flemington, NJ New Brunswick Donor Center 167 New Street New Brunswick, NJ Raritan Donor Center (Platelets Only) 1001 Route 202 Raritan, NJ Scotch Plains Donor Center 2279 South Avenue Scotch Plains, NJ n e w y o r k Brooklyn Donor Center 120 Lawrence Street Brooklyn, NY Citigroup Donor Center 53rd Street at Lexington Avenue Lower Level New York, NY MetLife Donor Center 200 Park Avenue Lobby Level New York, NY New York Blood Center Headquarters Upper East Side Donor Center 310 East 67th Street (Between 1st & 2nd Avenue) First Floor Lobby New York, NY Pergament Mall Donor Center 2791 Richmond Avenue (Above Verizon Wireless) Staten Island, NY Port Authority Donor Center 625 Eighth Avenue (Between 40th & 41st Street) Main Floor New York, NY Somerville Elks 375 Union Avenue Somerville, NJ Design/Copywriting Chandler Wilson Photography Chris Herder Photography, Leslie Gonzalez, Chandler Wilson 23

26 m i s s i o n To serve our community and provide the highest quality blood and stem cell products, donor and patient medical services, and innovative research.

27 v i s i o n To develop people and partnerships to continue to be recognized as a comprehensive center of excellence worldwide. v a l u e s Excellence Quality Service Leadership Innovation Compassion Respect Integrity Sharing Knowledge Maintaining Public Trust

28 310 east 67th street new york, ny n y b l o o d c e n t e r. o r g 2011 New York Blood Center. All rights reserved. Printed February 2011 by NYBC Corporate Communications Department.